We are live on ! Find out more
MSKCC

Memorial Sloan Kettering Cancer Center Portfolio holdings

AUM $24.6M
1-Year Est. Return 10.16%
This Fund
S&P 500
This Quarter Est. Return
+9.02%
1 Year Est. Return
+10.16%
3 Year Est. Return
-14.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$29.4M
AUM Growth
-$841K
Cap. Flow
-$606K
Cap. Flow %
-2.06%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CRBU icon
Caribou Biosciences
CRBU
+$606K

Sector Composition

Rank Sector Weight
1 Healthcare 39.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GDX icon
1
VanEck Gold Miners ETF
GDX
$27.6B
$17.8M 60.55%
738,500
– –
CRBU icon
2
Caribou Biosciences
CRBU
$165M
$5.74M 19.52%
544,196
-65,000
-11% -$606K
YMAB
3
DELISTED
Y-mAbs Therapeutics
YMAB
$2.76M 9.37%
191,176
– –
ORIC icon
4
Oric Pharmaceuticals
ORIC
$1.41B
$1.93M 6.55%
602,272
– –
ILMN icon
5
Illumina
ILMN
$29B
$1.18M 4.01%
6,360
– –

Similar funds

BRC
Bishop Rock Capital New York $24.3M AUM 20.73% 1-Year Est. Return
NAM
Nationwide Asset Management Columbus, Ohio $25.1M AUM 13.37% 1-Year Est. Return
TAAM
Top Ace Asset Management Hong Kong $25.3M AUM 23.27% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
AG
Appleton Group Appleton, Wisconsin $28.6M AUM 32.21% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM

Memorial Sloan Kettering Cancer Center's Q3 2022 Portfolio in Review

As of Q3 2022, Memorial Sloan Kettering Cancer Center held 5 positions worth $29.4M, down 2.8% from $30.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 0%. Memorial Sloan Kettering Cancer Center opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 33% a quarter earlier.

  • Memorial Sloan Kettering Cancer Center's biggest Q3 2022 reduction was Caribou Biosciences, cutting an estimated $606K.
  • Memorial Sloan Kettering Cancer Center's ten largest holdings make up 100% of its $29.4M portfolio in Q3 2022.
  • Memorial Sloan Kettering Cancer Center opened 0 new positions and closed 0 in Q3 2022.
  • Memorial Sloan Kettering Cancer Center's portfolio value fell 2.8% quarter-over-quarter to $29.4M.

Based on Memorial Sloan Kettering Cancer Center's 13F filing for Q3 2022, filed 14 Nov 2022.